Sign in

CIK 0001815776 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

LENZ Therapeutics, Inc.

Sign in to watch
Ticker
LENZ
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
844867570
Phone
858-925-7000
Business address
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075
Former names
Graphite Bio, Inc.
  1. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  2. 8-A12B Other Registration of Securities
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. S-1/A Offering Registration Statement
  7. UPLOAD Other SEC-generated Letter
  8. S-1/A Offering Registration Statement
  9. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. S-1/A Offering Registration Statement
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. UPLOAD Other SEC-generated Letter
  14. S-1 Offering Registration Statement
  15. DRSLTR Other Correspondence Related to Draft Registration Statement
  16. DRS/A Other Draft Registration Statement
  17. UPLOAD Other SEC-generated Letter
  18. DRS Other Draft Registration Statement
  19. D Other Notice of Sales of Unregistered Securities

Page 18 of 18 · 359 filings